Given the evidence that M2-like macrophages exert pro-tumour effects by suppressing T cell infiltration and cytotoxic T cell function50, this reprogramming of the TME is expected to enhance the efficacy of AXL-specific CAR T cell therapy. Here, AXL is linked to neoplasm.